Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today the opening of its cutting-edge Center of Excellence for Biologics and Cell and Gene Therapy in the heart of Research Triangle Park (RTP), North Carolina. The new facility expands Solvias’ global network of centers and reinforces its commitment to advancing transformative therapies for cancer and

Exploring use of Altamira’s RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option to negotiate licensing and supply agreement

LubioScience GmbH, Switzerland’s largest R&D reagent platform, got into a new partnership with Cayman Chemical, a global leader in biochemicals, assay kits, and lipid research tools. This partnership brings Cayman's innovative products and expert services to the Swiss research community, supporting advancements in cancer, neuroscience, metabolism, drug discovery, and more.

Ymmunobio and the Paul Scherrer Institute win Innosuisse innovation grant to develop a radio pharmaceutical with YB’s proprietary YB-800

abc biopply AG, a pioneer innovator of humanized multi-organoid disease models, and Preclina Inc., a preclinical contract research organization specializing in immune related disorders and humanized animal models, have announced a strategic collaboration. The partnership between the two companies will provide customers with end-to-end project planning on humanized preclinical models from early in

TransHeps offers objective, patient-specific iDILI (idiosyncratic drug-induced liver injury) causality assessments using patient blood samples. It can be easily integrated into clinical trial workflows. Their biomarker-driven technology helps pharmaceutical and biotech companies reduce clinical trial risks, avoid delays, and ensure safer drug development.